A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 12, Issue 2, 2009, Pages 233-242

  Austin, Peter ^a   Elia, Marinos ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASEPSIS; BATCH PROCESS; CLINICAL STUDY; CONTAMINATION; CONTAMINATION RATE; DRUG CONTAMINATION; DRUG INDUSTRY; DRUG MANUFACTURE; ENVIRONMENTAL FACTOR; META ANALYSIS (TOPIC); MICROBIAL CONTAMINATION; RISK ASSESSMENT; SYSTEMATIC REVIEW; DRUG FORMULATION; META ANALYSIS; METHODOLOGY; MICROCLIMATE; PHARMACY; REVIEW; RISK; STANDARD;

DRUG;

ASEPSIS; DRUG COMPOUNDING; DRUG CONTAMINATION; ENVIRONMENT, CONTROLLED; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SERVICES; RISK;

EID: 70349333715     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3jp4b     Document Type: Article

References (49)

1. Olivier LC, Kendoff D, Wolfhard U, Nast-Kolb D, Nazif Yazici M, Esche H. Modified syringe design prevents plunger-related contamination--results of contamination and flow-rate tests. J Hosp Infect 2003;53:140-3.
2. Sharp J. Quality in the manufacture of medicines and other healthcare products. London: Pharmaceutical Press, 2000:331-360.
3. Farwell J. Aseptic dispensing for NHS patients (Farwell report). London: Department of Health, 1995.
4. Beaney A. Quality Assurance of Aseptic Preparation Services. Pharmaceutical Press, 2006:107.
5. British Standards Institution. BS EN ISO 14-644-1: Cleanrooms and associated controlled environments-part 1: classification of air cleanliness. 1999.
6. Medicines Control Agency. Rules and guidance for pharmaceutical manufacturers and distributors. London: The Stationery Office, 2002:97-101.
7. Quality assurance of aseptic preparation services. In: Beaney A, ed. 3 ed. London: Pharmaceutical Press, 2001:44-46.
8. National Patient Safety Agency. Patient safety alert 20. 2007.
9. Department of Health. Breckenridge Report. London, 1976.
10. Audit Commission. A spoonful of sugar-recipes for risk reduction. London, 2001.
11. Septicaemia from infusion. Br Med J 1969;2:462-3.
12. Contaminated infusion fluids. Br Med J 1972;3:190-1.
13. Contamination of multiple-dose vials due to repeat use of syringes. Cmaj 1989;140:529-31.
14. Infections linked to lax handling of propofol. Am J Health Syst Pharm 1995;52:2061, 2066.
15. Bach A, Motsch J, Schmidt H, et al. In-use contamination of propofol. A clinical study. Eur J Anaesthesiol 1997;14:178-83.
16. Breheny F, McGechie D, Toohey M. Contamination of parenteral nutrition solutions not a hazard with additions made at ward level. Anaesth Intensive Care 1990;18:547-9.
17. Burke KG, Larson E, Maciorowski L, Adler DC. Evaluation of the sterility of thermodilution room-temperature injectate preparations. Crit Care Med 1986;14:503-4.
18. D'Arcy PF, Woodside W. Drug additives: a potential source of bacterial contamination of infusion fluids. Lancet; 2:96.
19. Dominik RH, Segebade IE, Taenzer V. Risk of microbial contamination of iodinated contrast media on multiple use of largevolume bottles. Eur J Radiol 1995;19:198-205.
20. Driver RP, Jr., Snyder IS, North FP, Fife TJ. Sterility of anesthetic and resuscitative drug syringes used in the obstetric operating room. Anesth Analg 1998;86:994-7.
21. Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet 2001;358:1989-92.
22. Ernerot L, Thoren S, Sandell E. Studies on microbial contamination of infusion fluids arising from drug additions and administration. Acta Pharm Suec 1973;10:141-6.
23. Farrington M, McGinnes J, Matthews I, Park GR. Do infusions of midazolam and propofol pose an infection risk to critically ill patients? Br J Anaesth 1994;72:415-7.
24. Francis AE. Contaminated infusion fluids. Lancet 1972;2:285-6.
25. Hansen EW, Nielsen PL. Intrinsic and extrinsic microbial contamination of home total parenteral nutrition manufactured in evainfusion bags (the i.v. bag). J Clin Pharm Ther 1987;12:325-31.
26. Haws JL, Herman N, Clark Y, Bjoraker R, Jones D. The chemical stability and sterility of sodium thiopental after preparation. Anesth Analg 1998;86:208-13.
27. Hernandez-Ramos I, Gaitan-Meza J, Garcia-Gaitan E, Leon-Ramirez AR, Justiniani-Cedeno N, Avila-Figueroa C. Extrinsic contamination of intravenous infusates administered to hospitalized children in Mexico. Pediatr Infect Dis J 2000;19:888-90.
28. James FM, George RH, Naiem H, White GJ. Bacteriologic aspects of epidural analgesia. Anesth Analg 1976;55:187-90.
29. Lawrence J, Turner M, Gilbert P. Microbial contamination and growth in total parenteral nutrition solutions. J Clin Pharm Ther 1988;13:151-7.
30. Magee L, Godsiff L, Matthews I, Farrington M, Park GR. Anaesthetic drugs and bacterial contamination. Eur J Anaesthesiol Suppl 1995;12:41-3.
31. Martin MV. The air/water syringe: a potential source of microbial contamination. Br Dent J 1998;184:278-9.
32. Melman D, Siegel DM. Prefilled syringes: safe and effective. Dermatol Surg 1999;25:492-3.
33. Mitrano FP, Baptista RJ, Newton DW, Augustine SC. Microbial contamination potential of solutions in prefilled disposable syringes used with a syringe pump. Am J Hosp Pharm 1986;43:78-80.
34. Oie S, Kamiya A. Particulate and microbial contamination in in-use admixed parenteral nutrition solutions. Biol Pharm Bull 2005;28:2268-70.
35. Reiter PD. Sterility of intravenous fat emulsion in plastic syringes. Am J Health Syst Pharm 2002;59:1857-9.
36. Riedinger MS, Shellock FG, Shah PK, Weissfeld AS, Ellrodt AG. Sterility of prefilled thermodilution cardiac output syringes maintained at room and ice temperatures. Heart Lung 1985;14:8-11.
37. Singh RF, Corelli RL, Guglielmo BJ. Sterility of unit dose syringes of filgrastim and sargramostim. Am J Hosp Pharm 1994;51:2811-2.
38. Soong WA. Bacterial contamination of propofol in the operating theatre. Anaesth Intensive Care 1999;27:493-6.
39. Takagi J, Khalidi N, Wolk RA, Tjolsen E, de Leon R, Wesley JR. Sterility of total parenteral nutrient solutions stored at room temperature for seven days. Am J Hosp Pharm 1989;46:973-7.
40. Trissel LA, Ogundele AB, Ingram DS, Saenz CA, Gentempo JA. Using medium-fill simulation to establish a benchmark microbiological contamination rate for lowrisk-level compounding. Am J Health Syst Pharm 2003;60:1853-5.
41. Weil DC, Arnow PM. Safety of refrigerated storage of admixed parenteral fluids. J Clin Microbiol 1988;26:1787-90.
42. Yorioka K, Oie S, Oomaki M, Imamura A, Kamiya A. Particulate and microbial contamination in in-use admixed intravenous infusions. Biol Pharm Bull 2006;29:2321-3.
43. Austin P, Dixson S. Hub fluid does not increase microbiological contamination of prepared and stored syringes. Pharm J 2006;276:47-49.
44. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians? Bmj 2008;336:995-8.
45. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Bmj 2008;336:924-6.
46. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol 2009.
47. D'Arcy PF, Woodside W. Drug additives: a potential source of bacterial contamination of infusion fluids. Lancet 1973;2:96.
48. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. 55 ed. Oxon: Pharmaceutical Press, 2008:822.
49. Beaney A, Goode J. A risk assessment of the ward-based preparation of parenteral medicines. Hospital Pharmacist 2003;10:306-8.